Advertisement
New Zealand markets closed
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5933
    -0.0001 (-0.02%)
     
  • NZD/EUR

    0.5544
    +0.0004 (+0.07%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    82.73
    -0.63 (-0.76%)
     
  • GOLD

    2,341.80
    -0.30 (-0.01%)
     
  • NASDAQ

    17,509.99
    +38.52 (+0.22%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • Dow Jones

    38,424.67
    -79.02 (-0.21%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • NZD/JPY

    91.9490
    +0.1830 (+0.20%)
     

Why Youngevity International Inc. Is Tanking Today

What happened

Shares of Youngevity International Inc. (NASDAQ: YGYI) were down 23.5% as of 10:56 a.m. EDT on Wednesday. There was no news from the California-based multilevel marketer. So why did Youngevity's share price tank?

Perhaps the best explanation is that when major marijuana stocks sneeze, Youngevity catches a cold. Several large marijuana stocks tumbled on Wednesday as the Canadian recreational marijuana market opened for business for the first time. Youngevity's entrance into the cannabidiol (CBD) beverage market appears to have tied the stock's fortunes to the rest of the cannabis industry.

Businessman looking down at falling chart.
Businessman looking down at falling chart.

Image source: Getty Images.

So what

Should Youngevity's share price drop just because Canadian marijuana stocks are falling? Not really.

ADVERTISEMENT

However, Youngevity stock has soared over the past few weeks, with the gains driven by the company's entrance into the CBD market. What goes up because of the cannabis opportunity can go down because of the cannabis opportunity.

The interesting thing, though, is that any letdown associated with the launch of the Canadian recreational marijuana market has absolutely no bearing on Youngevity's prospects. Canada hasn't legalized cannabis-infused beverages yet. That won't come until next year at the earliest.

Investors shouldn't dwell too much on the big swings by Youngevity -- either up or down. They're fueled primarily by a focus on the short term rather than the long term.

Now what

The primary thing to watch with Youngevity is the company's financial performance. Youngevity reports its third-quarter results in November. In its last quarter, the company posted modest year-over-year revenue growth but with a net loss of $656,000.

It's possible that Youngevity's launches of new CBD products will help spark financial improvement. However, investors are better off waiting to see for sure before buying Youngevity on its big pullback.

More From The Motley Fool

Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.